Proposed Data Collections Submitted for Public Comment and Recommendations, 66935-66936 [2013-26671]
Download as PDF
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Report of Verified Case of
Tuberculosis (RVCT), (OMB No. 0920–
0026 exp. 5/31/2014)—Extension—
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
In the United States, an estimated 10
to 15 million people are infected with
Mycobacterium tuberculosis and about
10% of these persons will develop
tuberculosis (TB) disease at some point
in their lives. The purpose of this
project is to continue ongoing national
tuberculosis surveillance using the
standardized Report of Verified Case of
Tuberculosis (RVCT). Data collected
using the RVCT help state and federal
infectious disease officials to assess
changes in the diagnosis and treatment
of TB, monitor trends in TB
epidemiology and outbreaks, and
develop strategies to meet the national
goal of TB elimination.
CDC currently conducts and
maintains the national TB surveillance
system (NTSS) pursuant to the
provisions of Section 301(a) of the
Public Service Act [42 U.S.C. 241] and
Section 306 of the Public Service Act
[42 U.S.C. 241(a)]. Data are collected by
60 reporting areas (the 50 states, the
District of Columbia, New York City,
Puerto Rico, and 7 jurisdictions in the
Pacific and Caribbean). The last major
revision of the RVCT data collection
66935
instrument was approved in 2009, in
consultation with CDC’s Division of
Tuberculosis Elimination (DTBE), state
and local health departments, and
partner organizations including the
National TB Controllers Association, the
Council for State and Territorial
Epidemiologists, and the Advisory
Committee for the Elimination of
Tuberculosis. No revisions to the RVCT
are proposed in this data collection
extension request.
CDC publishes an annual report using
RVCT data to summarize national TB
statistics and also periodically conducts
special analyses for publication to
further describe and interpret national
TB data. These data assist in public
health planning, evaluation, and
resource allocation. Reporting areas also
review and analyze their RVCT data to
monitor local TB trends, evaluate
program success, and focus resources to
eliminate TB.
No other Federal agency collects this
type of national TB data. In addition to
providing technical assistance on the
use of RVCT, CDC provides technical
support for reporting software. In this
request, CDC is requesting approval for
approximately 5,810 burden hours.
There is no cost to respondents except
for their time.
ESTIMATE OF ANNUALIZED BURDEN TABLE
Types of respondents
Form name
Number of
responses per
respondent
Number of
respondents
Average burden
per response
(in hours)
Total burden
(in hours)
Local, state, and territorial health departments ...........................................
RVCT Form
60
166
35/60
5,810
Total ................................................
..............................
..............................
..............................
..............................
5,810
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–26693 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
[60-Day–14–14BA]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to LeRoy Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Annual Survey of the National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP) Grantees—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
To improve access to cancer
screening, Congress passed the Breast
and Cervical Cancer Mortality
Prevention Act of 1990 (Public Law
101–354) which directed CDC to create
E:\FR\FM\07NON1.SGM
07NON1
66936
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP).
Currently, the NBCCEDP funds 67
grantees including all 50 states, the
District of Columbia, 5 U.S. territories,
and 11 American Indian/Alaska Native
tribes or tribal organizations. Grantees
provide screening services for breast
and cervical cancer to low-income,
uninsured, and underinsured women
who otherwise would not have access to
screening.
Since 1991, NBCCEDP-funded
grantees have served more than 4.3
million women, provided more than
10.7 million breast and cervical cancer
screening examinations, and diagnosed
more than 56,662 breast cancers, 3,206
invasive cervical cancers, and 152,470
premalignant cervical lesions, of which
41% were high-grade. As a
comprehensive, organized screening
program, the NBCCEDP supports
activities including program
management, partnership development,
public education and targeted outreach,
screening and diagnostic services,
patient navigation, quality assurance
and quality improvement, professional
development, data management and
utilization, and program monitoring and
evaluation. For clinical service delivery,
grantees fund health care providers in
their state/territory/tribe to deliver
breast and cervical cancer screening,
diagnostic evaluation, and treatment
referrals for women diagnosed with
cancer.
CDC issued a new Funding
Opportunity Announcement (FOA) to
support a new 5-year cooperative
agreement for the NBCCEDP effective
July 2012. This new FOA begins to shift
the NBCCEDP from a focus on direct
service provision to implementation of
expanded evidence-based activities
intended to increase rates of breast and
cervical cancer screening at the
population level. Though NBCCEDP
grantees continue to provide breast and
cervical cancer screening for uninsured
and underinsured women, CDC is
encouraging the implementation of
strategies to increase screening rates
beyond that of program-eligible women.
CDC plans to implement an annual
survey of NBCCEDP program directors
in order to assess program
implementation, particularly related to
these expanded population-based
efforts. The Web-based survey includes
questions on respondent background,
program activities, clinical service
delivery, monitoring and evaluation,
partnerships, training and technical
assistance needs, and program
management. Questions are of various
types including dichotomous and
multiple response. The estimated
burden per response is 45 minutes.
This assessment will enable CDC to
gauge its progress in meeting NBCCEDP
program goals, identify implementation
activities, monitor program transition to
efforts aimed at impacting populationbased screening, identify technical
assistance needs of state, tribe and
territorial health department cancer
control programs, and identify
implementation models with potential
to expand and transition to new settings
to increase program impact and reach.
The assessment will identify successful
activities that should be maintained,
replicated, or expanded as well as
provide insight into areas that need
improvement.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hr)
Total burden
(in hr)
NBCCEDP Program Directors.
CDC National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) Grantee Survey of Program Implementation.
67
1
45/60
50
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–26671 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
This document may be
obtained at the following link:
www.cdc.gov/niosh/docs/2014-100/.
tkelley on DSK3SPTVN1PROD with NOTICES
G.
Scott Dotson, Ph.D. CIH, NIOSH
Education and Information Division,
Taft Laboratories Building, 4676
Columbia Parkway, Cincinnati, Ohio,
45226. (513) 533–8540.
Dated: November 1, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26678 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis (ACET)
FOR FURTHER INFORMATION CONTACT:
Issuance of Final Guidance Publication
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
16:24 Nov 06, 2013
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
announces the availability of the
following publication: ‘‘Current
Intelligence Bulletin 66—Derivation of
Immediately Dangerous to Life or Health
(IDLH) Values’’ [NIOSH 2014–100].
SUMMARY:
ADDRESSES:
[Docket Number NIOSH–156]
VerDate Mar<15>2010
Notice of issuance of final
guidance publication.
ACTION:
Jkt 232001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 11:00 a.m.–3:30 p.m.,
December 3, 2013
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
E:\FR\FM\07NON1.SGM
07NON1
Agencies
[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Pages 66935-66936]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26671]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-14-14BA]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to LeRoy Richardson, 1600 Clifton Road, MS-D74, Atlanta,
GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Annual Survey of the National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) Grantees--New--National Center for Chronic
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
To improve access to cancer screening, Congress passed the Breast
and Cervical Cancer Mortality Prevention Act of 1990 (Public Law 101-
354) which directed CDC to create
[[Page 66936]]
the National Breast and Cervical Cancer Early Detection Program
(NBCCEDP). Currently, the NBCCEDP funds 67 grantees including all 50
states, the District of Columbia, 5 U.S. territories, and 11 American
Indian/Alaska Native tribes or tribal organizations. Grantees provide
screening services for breast and cervical cancer to low-income,
uninsured, and underinsured women who otherwise would not have access
to screening.
Since 1991, NBCCEDP-funded grantees have served more than 4.3
million women, provided more than 10.7 million breast and cervical
cancer screening examinations, and diagnosed more than 56,662 breast
cancers, 3,206 invasive cervical cancers, and 152,470 premalignant
cervical lesions, of which 41% were high-grade. As a comprehensive,
organized screening program, the NBCCEDP supports activities including
program management, partnership development, public education and
targeted outreach, screening and diagnostic services, patient
navigation, quality assurance and quality improvement, professional
development, data management and utilization, and program monitoring
and evaluation. For clinical service delivery, grantees fund health
care providers in their state/territory/tribe to deliver breast and
cervical cancer screening, diagnostic evaluation, and treatment
referrals for women diagnosed with cancer.
CDC issued a new Funding Opportunity Announcement (FOA) to support
a new 5-year cooperative agreement for the NBCCEDP effective July 2012.
This new FOA begins to shift the NBCCEDP from a focus on direct service
provision to implementation of expanded evidence-based activities
intended to increase rates of breast and cervical cancer screening at
the population level. Though NBCCEDP grantees continue to provide
breast and cervical cancer screening for uninsured and underinsured
women, CDC is encouraging the implementation of strategies to increase
screening rates beyond that of program-eligible women.
CDC plans to implement an annual survey of NBCCEDP program
directors in order to assess program implementation, particularly
related to these expanded population-based efforts. The Web-based
survey includes questions on respondent background, program activities,
clinical service delivery, monitoring and evaluation, partnerships,
training and technical assistance needs, and program management.
Questions are of various types including dichotomous and multiple
response. The estimated burden per response is 45 minutes.
This assessment will enable CDC to gauge its progress in meeting
NBCCEDP program goals, identify implementation activities, monitor
program transition to efforts aimed at impacting population-based
screening, identify technical assistance needs of state, tribe and
territorial health department cancer control programs, and identify
implementation models with potential to expand and transition to new
settings to increase program impact and reach. The assessment will
identify successful activities that should be maintained, replicated,
or expanded as well as provide insight into areas that need
improvement.
OMB approval is requested for three years. Participation is
voluntary and there are no costs to respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
--------------------------------------------------------------------------------------------------------------------------------------------------------
NBCCEDP Program Directors.................... CDC National Breast and Cervical 67 1 45/60 50
Cancer Early Detection Program
(NBCCEDP) Grantee Survey of Program
Implementation.
--------------------------------------------------------------------------------------------------------------------------------------------------------
LeRoy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2013-26671 Filed 11-6-13; 8:45 am]
BILLING CODE 4163-18-P